Found: 82
Select item for more details and to access through your institution.
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34175-y
- By:
- Publication type:
- Article
Radiographic Progression of a Chiari I Malformation After Minor Head Trauma: Final Increment of Obstruction to Create Pathophysiology.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Targeting miR-23a in CD8<sup>+</sup> cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 12, p. 5352, doi. 10.1172/JCI76561
- By:
- Publication type:
- Article
EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094281
- By:
- Publication type:
- Article
Myeloablative Temozolomide Enhances CD8<sup>+</sup> T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059082
- By:
- Publication type:
- Article
A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031046
- By:
- Publication type:
- Article
A Novel Method for Volumetric MRI Response Assessment of Enhancing Brain Tumors.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016031
- By:
- Publication type:
- Article
INTRODUCTION: Update on adult neuro-oncology.
- Published in:
- Neurosurgical Focus, 2018, v. 44, n. 6, p. 1, doi. 10.3171/2018.3.FOCUS18149
- By:
- Publication type:
- Article
Generation of anti-idiotypic reagents in the EGFRvIII tumor-associated antigen system.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 50, n. 12, p. 639, doi. 10.1007/s00262-001-0243-5
- By:
- Publication type:
- Article
Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5367, doi. 10.3390/cancers13215367
- By:
- Publication type:
- Article
Enhanced Oncolytic Virotherapy Through Oxidative Stress Inhibition.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 11, p. 1981, doi. 10.1038/mt.2013.227
- By:
- Publication type:
- Article
Immunotherapy of malignant brain tumors.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 70, doi. 10.1111/j.1600-065X.2008.00603.x
- By:
- Publication type:
- Article
Targeting Immunometabolism in Glioblastoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.696402
- By:
- Publication type:
- Article
IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1085547
- By:
- Publication type:
- Article
Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 10, p. 1391, doi. 10.1093/neuonc/nox090
- By:
- Publication type:
- Article
Vaccination strategies for neuro-oncology.
- Published in:
- Neuro-Oncology, 2015, v. 17, p. vii15, doi. 10.1093/neuonc/nov159
- By:
- Publication type:
- Article
Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 8, p. 1043, doi. 10.1093/neuonc/nov071
- By:
- Publication type:
- Article
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 6, p. 854, doi. 10.1093/neuonc/nou348
- By:
- Publication type:
- Article
Epidermal growth factor receptor and variant III targeted immunotherapy.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_8, p. viii20, doi. 10.1093/neuonc/nou236
- By:
- Publication type:
- Article
Immunotherapy advances for glioblastoma.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 11, p. 1441, doi. 10.1093/neuonc/nou212
- By:
- Publication type:
- Article
PATIENT-DERIVED XENOGRAFTS MIRROR THE PROTEOMIC PROFILE OF HUMAN GLIOBLASTOMA: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii38, doi. 10.1093/neuonc/nou208.57
- By:
- Publication type:
- Article
IDH1 MUTATIONS AS A IMMUNOTHERAPEUTIC TARGET FOR BRAIN TUMORS.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii40, doi. 10.1093/neuonc/nou208.65
- By:
- Publication type:
- Article
ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN RECURRENT GLIOBLASTOMA (GBM): FIRST PHASE I CLINICAL TRIAL EVALUATING THE INTRATUMORAL ADMINISTRATION.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii43, doi. 10.1093/neuonc/nou209.5
- By:
- Publication type:
- Article
Editorial on “Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial”.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 2, p. 169, doi. 10.1093/neuonc/not311
- By:
- Publication type:
- Article
Clinical trial end points for high-grade glioma: the evolving landscape*.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 3, p. 353, doi. 10.1093/neuonc/noq203
- By:
- Publication type:
- Article
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 3, p. 324, doi. 10.1093/neuonc/noq157
- By:
- Publication type:
- Article
Immunotherapy coming of age: What will it take to make it standard of care for glioblastoma?
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 1, p. 3, doi. 10.1093/neuonc/noq169
- By:
- Publication type:
- Article
Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: Case study.
- Published in:
- Neuro-Oncology, 2005, v. 7, n. 1, p. 90, doi. 10.1215/S1152851703000589
- By:
- Publication type:
- Article
Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 2, p. 134, doi. 10.1215/S1152851703000413
- By:
- Publication type:
- Article
Poliovirus receptor CD155--targeted oncolysis of glioma.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 3, p. 208, doi. 10.1215/S1152851703000577
- By:
- Publication type:
- Article
Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 2, p. 145, doi. 10.1215/S1152851703000498
- By:
- Publication type:
- Article
Low-dose whole brain radiotherapy combined with radiosurgery for primary CNS lymphoma achieving partial response to induction methotrexate-based chemotherapy.
- Published in:
- Journal of Radiosurgery & SBRT, 2014, v. 3, n. 1, p. 37
- By:
- Publication type:
- Article
GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody.
- Published in:
- PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0236374
- By:
- Publication type:
- Article
Proteomic and immunologic analyses of brain tumor exosomes.
- Published in:
- FASEB Journal, 2009, v. 23, n. 5, p. 1541, doi. 10.1096/fj.08-122184
- By:
- Publication type:
- Article
Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses.
- Published in:
- 2020
- By:
- Publication type:
- journal article
EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma.
- Published in:
- Brain Pathology, 2009, v. 19, n. 4, p. 713, doi. 10.1111/j.1750-3639.2009.00318.x
- By:
- Publication type:
- Article
Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.
- Published in:
- Journal of Neurochemistry, 2015, v. 133, n. 5, p. 730, doi. 10.1111/jnc.13032
- By:
- Publication type:
- Article
Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac025
- By:
- Publication type:
- Article
IgE, allergy, and risk of glioma: Update from the San Francisco Bay Area Adult Glioma Study in the Temozolomide era.
- Published in:
- International Journal of Cancer, 2009, v. 125, n. 3, p. 680, doi. 10.1002/ijc.24369
- By:
- Publication type:
- Article
Imaging of Convection Enhanced Delivery of Toxins in Humans.
- Published in:
- Toxins, 2011, v. 3, n. 3, p. 201, doi. 10.3390/toxins3030201
- By:
- Publication type:
- Article
Monitoring Radiographic Brain Tumor Progression.
- Published in:
- Toxins, 2011, v. 3, n. 3, p. 191, doi. 10.3390/toxins3030191
- By:
- Publication type:
- Article
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
- Published in:
- Nature, 2015, v. 519, n. 7543, p. 366, doi. 10.1038/nature14320
- By:
- Publication type:
- Article
A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-020-00273-5
- By:
- Publication type:
- Article
Oncolytic polio virotherapy of cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 21, p. 3277, doi. 10.1002/cncr.28862
- By:
- Publication type:
- Article
Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 23, p. 5351, doi. 10.1002/cncr.26188
- By:
- Publication type:
- Article
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Phase 1 Trial of Temozolomide Plus Irinotecan Plus O<sup>6</sup>-Benzylguanine in Adults With Recurrent Malignant Glioma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 13, p. 2964, doi. 10.1002/cncr.24336
- By:
- Publication type:
- Article
Toxin-Based Targeted Therapy for Malignant Brain Tumors.
- Published in:
- Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/480429
- By:
- Publication type:
- Article
Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 151, n. 1, p. 55, doi. 10.1007/s11060-020-03598-2
- By:
- Publication type:
- Article